PharmaMarketing Summit Returns This May
Executives in the pharma marketing space will be in attendance
Next month (May 12-13), the PharmaMarketing Summit will be returning to Boston, MA. The summit brings leading pharmaceutical marketing executives and innovative suppliers and service providers together at the Encore Boston Harbor.
The event’s content is aligned with key pharma marketing challenges and interests, relevant market developments, and practical and progressive ideas and strategies adopted by successful pioneers. It effectively unites experts in an exclusive networking environment, providing the opportunity to pre-schedule one-on-one physical business meetings with key leading and forward-thinking executives.
Delegates that attended in the past include:
- Neurocrine Biosciences – VP – Marketing
- Proteon Therapeutics Inc – Senior Vice President, Marketing
- Horizon Pharma – Director
- Takeda Pharmaceuticals – Director of Marketing Capabilities
- Teva Pharmaceuticals – Marketing Senior Director
- Baxalta – Marketing Director
- BioMarin – Executive Director – North America Brand Management
- Daiichi Sankyo Inc. – Executive Director – Thrombosis
- Dermira Inc. – VP – Marketing & Market Access
- Etc.
For more information, visit https://bit.ly/3OefgXd or directly contact directly Isidora Avraam at [email protected].
FDA Approves Actemra Biosimilar
January 31st 2025Celltrion’s Avtozma has been indicated for the treatment of giant cell arteritis, polyarticular juvenile idiopathic arthritis, rheumatoid arthritis, systemic juvenile idiopathic arthritis, and COVID-19—in the same dosages and formulations as its tocilizumab reference product.
